Topical composition containing a substance P antagonist

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514210, 514293, 514305, 514315, 514410, 514416, 514422, 514423, 514426, 514438, 514461, 514613, 514617, 514663, 514646, A61K 3800, A61K 31135

Patent

active

059728922

ABSTRACT:
The invention relates to a therapeutic composition for topical application containing at least one product with an irritant side effect and a substance P antagonist for reducing or even eliminating the irritant effect of this product.
It also relates to the use of a substance P antagonist for the preparation of a pharmaceutical composition for topical application containing at least one product with an irritant side effect for reducing or even eliminating the irritant effect of this product.
The substance P antagonist may be a peptide compound or a nitrogen-containing compound or a nitrogen-, sulphur- or oxygen-containing heterocyclic compound.

REFERENCES:
patent: 5569662 (1996-10-01), Satake et al.
Beding-Basrekow et al, Exp. Eye Res., 50(1), 21-26, Jan. 1990.
Anderson et al, Eu.J. Pharmacol 209, 175-183, 1991.
Wallengren, Br. J. Dermatoe., 124, 324-328, 1991.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Topical composition containing a substance P antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topical composition containing a substance P antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical composition containing a substance P antagonist will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-764490

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.